Table S8 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

Joshua D. Thomas; Aleksandr V. Yurkovetskiy; Mao Yin; Natalya D. Bodyak; Shuyi Tang; Marina Protopopova; Eugene Kelleher; Brian Jones; Liping Yang; Daniel Custar; Kalli C. Catcott; Damon R. Demady; Scott D. Collins; Ling Xu; Charlie Bu; LiuLiang Qin; Elena Ter‐Ovanesyan; Marc Damelin; Dorin Toader; Timothy B. Lowinger

doi:10.1158/1535-7163.25523466

Abstract

Table shows Tabulated cell growth inhibition data for NCI-N87 and MDA-MB231 cells in monoculture and coculture when treated with ADCs T-16, T-17, and T-18

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Thomas et al. (2024) studied this question.

synapsesocial.com/papers/68e70c4bb6db643587685e0c https://doi.org/10.1158/1535-7163.25523466

View Full Paper

Ask AI

Bookmark

Share

Table S8 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

Abstract

Discussion

Cite This Study

Table S8 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers